SCHEMBL19217048

SCHEMBL19217048

O=C(/C=C/c1ccc(OCCCNC(C(=O)OC2CCCC2)C2CCCCC2)cc1)NO

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 7/20 0.44
HDAC6 Q9UBN7 7/20 0.44
HDAC4 P56524 6/20 0.44
HDAC1 Q13547 6/20 0.44
HDAC8 Q9BY41 5/20 0.44
HDAC5 Q9UQL6 4/20 0.44
HDAC2 Q92769 4/20 0.44
HDAC7 Q8WUI4 3/20 0.44
HDAC10 Q969S8 3/20 0.44
HDAC11 Q96DB2 3/20 0.44
HDAC9 Q9UKV0 3/20 0.44
MEF2D Q14814 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
CYP1A2 P05177 1/20 0.39
RAB9A P51151 1/20 0.39
CDK9 P50750 1/20 0.39
KMT2A Q03164 3/20 0.39
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8195919 1.00 HDAC3 (0.44) HDAC3HDAC6HDAC4HDAC1HDAC8
SCHEMBL3457451 0.88 HDAC3 (0.49) HDAC3HDAC6HDAC4HDAC1HDAC8
SCHEMBL3457444 0.88 HDAC3 (0.49) HDAC3HDAC6HDAC4HDAC1HDAC8
SCHEMBL13539401 0.85 TAS1R3 (0.37) SMN1; SMN2RAB9AKMT2AMEN1MAPT
SCHEMBL1411125 0.83 TAS1R3 (0.45) HDAC3HDAC6HDAC4HDAC1HDAC8
SCHEMBL1411128 0.83 TAS1R3 (0.45) HDAC3HDAC6HDAC4HDAC1HDAC8
SCHEMBL1411131 0.83 TAS1R3 (0.45) HDAC3HDAC6HDAC4HDAC1HDAC8
SCHEMBL12810113 0.83 HDAC3 (0.56) HDAC3HDAC6HDAC4HDAC1HDAC8
SCHEMBL19723001 0.83 HDAC3 (0.56) HDAC3HDAC6HDAC4HDAC1HDAC8
SCHEMBL19217096 0.81 SAE1 (0.37) HDAC3HDAC6HDAC4HDAC1HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2069291-B1 HDAC INHIBITORS GLAXOSMITHKLINE IP DEV LTD (GB) 2017-12-20 EP disclosed
US-9725407-B2 HDAC inhibitors GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2017-08-08 US disclosed